A Comparative Analysis of Biosimilar vs. Originator Filgrastim in Combination With Plerixafor for Stem Cell Mobilization in Lymphoma and Multiple Myeloma: A Propensity-Score Weighted Multicenter Approach
American Journal of Hematology - United States
doi 10.1002/ajh.24817
Full Text
Open PDFAbstract
Available in full text
Categories
Date
July 24, 2017
Authors
Publisher
Wiley